Federal Contractor Profile
Paratek Pharmaceuticals, INC
$265M obligated·3 awards·2 agencies·2 NAICS
Federal Contracts
Showing award actions 1–9 of 9 funded award actions, most recent first.
- Contracts with positive obligations
- 3
- Funded award actions shown
- 9
- Obligations shown
- $265M
- Awarding agencies
- 2
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of October 13, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Feb 19, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $17M |
| Mar 31, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $5.0M |
| Feb 6, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $17M |
| Nov 29, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $808K |
| Dec 15, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $36M |
| Sep 23, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $32M |
| Jul 29, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $43K |
| Mar 27, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $97M |
| Dec 18, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00001 | 541714 | ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | $59M |
Get Alerted Before Paratek Pharmaceuticals, INC's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free